Resmed Inc RMD:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 05/03/24 EDT

216.98UNCH (UNCH)

Volume

28,711

216.98

-1.17 (-0.54%)

Volume

625,230

52 week range

132.24 - 240.09

Open219.63
Day High221.40
Day Low216.72
Prev Close218.15
52 Week High240.09
52 Week High Date05/03/23
52 Week Low132.24
52 Week Low Date10/27/23

Key Stats

Market Cap31.876B
Shares Out146.91M
10 Day Average Volume1.64M
Dividend1.92
Dividend Yield0.88%
Beta0.70
YTD % Change26.14

KEY STATS

Open219.63
Day High221.40
Day Low216.72
Prev Close218.15
52 Week High240.09
52 Week High Date05/03/23
52 Week Low132.24
52 Week Low Date10/27/23
Market Cap31.876B
Shares Out146.91M
10 Day Average Volume1.64M
Dividend1.92
Dividend Yield0.88%
Beta0.70
YTD % Change26.14

RATIOS/PROFITABILITY

EPS (TTM)6.50
P/E (TTM)33.40
Fwd P/E (NTM)26.71
EBITDA (TTM)1.47B
ROE (TTM)22.39%
Revenue (TTM)4.584B
Gross Margin (TTM)55.78%
Net Margin (TTM)20.91%
Debt To Equity (MRQ)21.75%

EVENTS

Earnings Date08/01/2024(est)
Ex Div Date05/08/2024
Div Amount0.48
Split Date-
Split Factor-

Latest On Resmed Inc

Resmed CEO Mick Farrell goes one-on-one with Jim CramerApril 29, 2024CNBC.com
Stocks making the biggest moves midday: Microsoft, Alphabet, Snap and moreApril 26, 2024CNBC.com
Stocks making the biggest moves midday: United Airlines, Travelers, Abbott LabsApril 17, 2024CNBC.com
Stocks making the biggest premarket moves: Eli Lilly, Travelers, Alcoa and moreApril 17, 2024CNBC.com
Jim Cramer goes Mad for March with a special Final Four version of Lightning RoundApril 5, 2024CNBC.com

Content From Our Affiliates

ResMed price target raised to $195 from $180 at UBSApril 28, 2024TipRanks
ResMed price target lowered to $200 from $205 at OppenheimerApril 26, 2024TipRanks
ResMed price target raised to $236 from $224 at NeedhamApril 26, 2024TipRanks
ResMed price target raised to $200 from $187 at RBC CapitalApril 26, 2024TipRanks
RBC Capital Sticks to Their Hold Rating for Resmed (RMD)April 26, 2024TipRanks

Profile

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB...

Michael Farrell

Chairman of the Board, Chief Executive Officer

Peter Farrell Ph.D.

Chairman Emeritus

Brett Sandercock

Chief Financial Officer

Urvashi Tyagi

Chief Technology Officer

Todd Friedman

Chief Information Security Officer

Michael Rider

General Counsel, Company Secretary, Chief Legal Officer

Address

9001 Spectrum Center Blvd

San Diego, CA

92123-1438

United States

https://www.resmed.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
IDXX IDEXX Laboratories Inc	480.60	+4.78	+1.00%
STE STERIS plc	207.82	+1.58	+0.77%
HOLX Hologic Inc	76.54	+0.63	+0.83%
A Agilent Technologies Inc	139.45	+1.93	+1.40%
WAT Waters Corp	321.25	+5.67	+1.80%